Fri, Apr 18, 2014, 8:23 PM EDT - U.S. Markets closed for Good Friday

Recent

% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • eyesandears51 eyesandears51 Apr 30, 2013 10:29 AM Flag

    VRTX: Strong Medium and Long Term Prospects...Be Cautious for the Next Two Weeks.

    One measure of investor expectation is to follow options. The preponderance of volume for both May 18 call and put contract is decisively below $ 75. Stock technical’s are also under stress. RSI is declining, and the stochastic’s are telegraphing a possible overbought condition. The market stage is framed today by the earnings miss at Phizer and the weakness of the big three biotech’s, Biogen, GILD, Celgene. Even high beta Regeneron is correcting. While I am positive on VRTX, in the medium term and beyond, the stock is under pressure for the next several weeks. The stock could breach $ 75 this week.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • johnf50@rocketmail.com johnf50 Apr 30, 2013 4:06 PM Flag

      And 90% of options buyers lose money... so your point is that there is a 10% probability the stock will end up below $75... which also implies a 90% probability this will be above $75 so that both the put and call buyers lose money... while the writers, in this case, the money managers who own the stock the options are being written on, make a nice premium on selling you hopes and dreams.

      This is going up. Sorry.

      Sentiment: Hold

    • While officers can sell stock from time to diversify their holdings, 36 insider sales by the CEO, CFO and other officers , and 1 buy is a bit lopsided and could reflect concern that the stock is overextended in the near term. This may be confirming the option contracts pointing to a price below $ 75.

 
VRTX
64.17-0.22(-0.34%)Apr 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Weibo Corporation
NasdaqGSThu, Apr 17, 2014 4:00 PM EDT